reviewNature reviews. CancerJun 12, 2024Closed access

Defining clinically useful biomarkers of immune checkpoint inhibitors in solid tumours

AMAshley M. HolderADAikaterini DedeiliaKSKailan Sierra-DavidsonSCSonia CohenDLDavid Liu

The University of Texas MD Anderson Cancer Center · Massachusetts General Hospital · +2 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

224
total citations
FWCI
56.32
Percentile
100%
References
271
Citations per year

Authors

7

Topics & keywords

Topics
Keywords
  • Microsatellite instability
  • Medicine
  • Clinical trial
  • Immune checkpoint
  • Biomarker
  • Cancer
  • Immune system
  • Pembrolizumab
UN Sustainable Development Goals
  • Zero hunger
No related works found for this paper.